カテゴリー： 世界, 医療/バイオ, LP Information

世界の伝染性軟属腫（MC）治療市場予測 2023年-2029年

【英語タイトル】Global Molluscum Contagiosum (MC) Treatment Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC07102）・商品コード：LP23DC07102
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：105
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の伝染性軟属腫（MC）治療市場」は、過去の販売実績から2022年の世界の伝染性軟属腫（MC）治療の総販売量を検討し、2023年から2029年の予測される伝染性軟属腫（MC）治療の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の伝染性軟属腫（MC）治療の市場規模を掲載し、XXX百万米ドル規模の世界の伝染性軟属腫（MC）治療市場の詳細な分析を提供します。本インサイトレポートは、世界の伝染性軟属腫（MC）治療業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の伝染性軟属腫（MC）治療市場における各社の独自のポジションをより深く理解するために、伝染性軟属腫（MC）治療製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の伝染性軟属腫（MC）治療市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。伝染性軟属腫（MC）治療の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。伝染性軟属腫（MC）治療の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。伝染性軟属腫（MC）治療のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

伝染性軟属腫（MC）治療の世界主要メーカーとしては、Competition Deep Dive、 Novan, Inc.、 Veloce Biopharma、 Gurina Foundation、 Azafaros、 Polaryx Therapeutics、 Abbott Medtronic、 Merck & Co., Inc.、 Pfizer Inc.、 Siemens Healthcare GmbH、 Novartis AGなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の伝染性軟属腫（MC）治療市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では伝染性軟属腫（MC）治療市場をセグメンテーションし、種類別 (凍結療法、免疫調節療法、局所療法)、用途別 (病院、皮膚科クリニック、免疫不全患者)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：凍結療法、免疫調節療法、局所療法

・用途別区分：病院、皮膚科クリニック、免疫不全患者

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の伝染性軟属腫（MC）治療市場の10年間の市場状況・展望は？
・世界および地域別に見た伝染性軟属腫（MC）治療市場成長の要因は何か？
・伝染性軟属腫（MC）治療の市場機会はエンドマーケットの規模によってどのように変化するのか？
・伝染性軟属腫（MC）治療のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：伝染性軟属腫（MC）治療の年間販売量2018-2029、地域別現状・将来分析
・伝染性軟属腫（MC）治療の種類別セグメント：凍結療法、免疫調節療法、局所療法
・伝染性軟属腫（MC）治療の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・伝染性軟属腫（MC）治療の用途別セグメント：病院、皮膚科クリニック、免疫不全患者
・伝染性軟属腫（MC）治療の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の伝染性軟属腫（MC）治療市場
・企業別のグローバル伝染性軟属腫（MC）治療市場データ：2018-2023年の年間販売量、市場シェア
・企業別の伝染性軟属腫（MC）治療の年間売上：2018-2023年の売上、市場シェア
・企業別の伝染性軟属腫（MC）治療販売価格
・主要企業の伝染性軟属腫（MC）治療生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

伝染性軟属腫（MC）治療の地域別レビュー
・地域別の伝染性軟属腫（MC）治療市場規模2018-2023：年間販売量、売上
・主要国別の伝染性軟属腫（MC）治療市場規模2018-2023：年間販売量、売上
・南北アメリカの伝染性軟属腫（MC）治療販売の成長
・アジア太平洋の伝染性軟属腫（MC）治療販売の成長
・ヨーロッパの伝染性軟属腫（MC）治療販売の成長
・中東・アフリカの伝染性軟属腫（MC）治療販売の成長

南北アメリカ市場
・南北アメリカの国別の伝染性軟属腫（MC）治療販売量、売上（2018-2023）
・南北アメリカの伝染性軟属腫（MC）治療の種類別販売量
・南北アメリカの伝染性軟属腫（MC）治療の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の伝染性軟属腫（MC）治療販売量、売上（2018-2023）
・アジア太平洋の伝染性軟属腫（MC）治療の種類別販売量
・アジア太平洋の伝染性軟属腫（MC）治療の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の伝染性軟属腫（MC）治療販売量、売上（2018-2023）
・ヨーロッパの伝染性軟属腫（MC）治療の種類別販売量
・ヨーロッパの伝染性軟属腫（MC）治療の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の伝染性軟属腫（MC）治療販売量、売上（2018-2023）
・中東・アフリカの伝染性軟属腫（MC）治療の種類別販売量
・中東・アフリカの伝染性軟属腫（MC）治療の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・伝染性軟属腫（MC）治療の製造コスト構造分析
・伝染性軟属腫（MC）治療の製造プロセス分析
・伝染性軟属腫（MC）治療の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・伝染性軟属腫（MC）治療の主要なグローバル販売業者
・伝染性軟属腫（MC）治療の主要なグローバル顧客

地域別の伝染性軟属腫（MC）治療市場予測レビュー
・地域別の伝染性軟属腫（MC）治療市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・伝染性軟属腫（MC）治療の種類別市場規模予測
・伝染性軟属腫（MC）治療の用途別市場規模予測

主要企業分析
Competition Deep Dive、 Novan, Inc.、 Veloce Biopharma、 Gurina Foundation、 Azafaros、 Polaryx Therapeutics、 Abbott Medtronic、 Merck & Co., Inc.、 Pfizer Inc.、 Siemens Healthcare GmbH、 Novartis AG
・企業情報
・伝染性軟属腫（MC）治療製品
・伝染性軟属腫（MC）治療販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Molluscum Contagiosum (MC) Treatment market size is projected to grow from US$ 2794.9 million in 2022 to US$ 3981.9 million in 2029; it is expected to grow at a CAGR of 5.2% from 2023 to 2029.
United States market for Molluscum Contagiosum (MC) Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Molluscum Contagiosum (MC) Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Molluscum Contagiosum (MC) Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Molluscum Contagiosum (MC) Treatment players cover Competition Deep Dive, Novan, Inc., Veloce Biopharma, Gurina Foundation, Azafaros, Polaryx Therapeutics, Abbott Medtronic, Merck & Co., Inc. and Pfizer Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Molluscum contagiosum is an infection caused by a poxvirus (molluscum contagiosum virus). The result of the infection is usually a benign, mild skin disease characterized by lesions (growths) that may appear anywhere on the body. There are several treatment options available for MC, including Cryotherapy, Curettage, Topical medications and Laser therapy.
LPI (LP Information)’ newest research report, the “Molluscum Contagiosum (MC) Treatment Industry Forecast” looks at past sales and reviews total world Molluscum Contagiosum (MC) Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Molluscum Contagiosum (MC) Treatment sales for 2023 through 2029. With Molluscum Contagiosum (MC) Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molluscum Contagiosum (MC) Treatment industry.
This Insight Report provides a comprehensive analysis of the global Molluscum Contagiosum (MC) Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molluscum Contagiosum (MC) Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molluscum Contagiosum (MC) Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molluscum Contagiosum (MC) Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molluscum Contagiosum (MC) Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Molluscum Contagiosum (MC) Treatment market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Cryotherapy
Immune-modulating Therapies
Topical Therapies
Segmentation by application
Hospital
Skin Clinics
Immunocompromised Patients
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Competition Deep Dive
Novan, Inc.
Veloce Biopharma
Gurina Foundation
Azafaros
Polaryx Therapeutics
Abbott Medtronic
Merck & Co., Inc.
Pfizer Inc.
Siemens Healthcare GmbH
Novartis AG
Key Questions Addressed in this Report
What is the 10-year outlook for the global Molluscum Contagiosum (MC) Treatment market?
What factors are driving Molluscum Contagiosum (MC) Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Molluscum Contagiosum (MC) Treatment market opportunities vary by end market size?
How does Molluscum Contagiosum (MC) Treatment break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Molluscum Contagiosum (MC) Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Molluscum Contagiosum (MC) Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Molluscum Contagiosum (MC) Treatment by Country/Region, 2018, 2022 & 2029
2.2 Molluscum Contagiosum (MC) Treatment Segment by Type
2.2.1 Cryotherapy
2.2.2 Immune-modulating Therapies
2.2.3 Topical Therapies
2.3 Molluscum Contagiosum (MC) Treatment Sales by Type
2.3.1 Global Molluscum Contagiosum (MC) Treatment Sales Market Share by Type (2018-2023)
2.3.2 Global Molluscum Contagiosum (MC) Treatment Revenue and Market Share by Type (2018-2023)
2.3.3 Global Molluscum Contagiosum (MC) Treatment Sale Price by Type (2018-2023)
2.4 Molluscum Contagiosum (MC) Treatment Segment by Application
2.4.1 Hospital
2.4.2 Skin Clinics
2.4.3 Immunocompromised Patients
2.5 Molluscum Contagiosum (MC) Treatment Sales by Application
2.5.1 Global Molluscum Contagiosum (MC) Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Molluscum Contagiosum (MC) Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Molluscum Contagiosum (MC) Treatment Sale Price by Application (2018-2023)
3 Global Molluscum Contagiosum (MC) Treatment by Company
3.1 Global Molluscum Contagiosum (MC) Treatment Breakdown Data by Company
3.1.1 Global Molluscum Contagiosum (MC) Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Molluscum Contagiosum (MC) Treatment Sales Market Share by Company (2018-2023)
3.2 Global Molluscum Contagiosum (MC) Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Molluscum Contagiosum (MC) Treatment Revenue by Company (2018-2023)
3.2.2 Global Molluscum Contagiosum (MC) Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Molluscum Contagiosum (MC) Treatment Sale Price by Company
3.4 Key Manufacturers Molluscum Contagiosum (MC) Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Molluscum Contagiosum (MC) Treatment Product Location Distribution
3.4.2 Players Molluscum Contagiosum (MC) Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Molluscum Contagiosum (MC) Treatment by Geographic Region
4.1 World Historic Molluscum Contagiosum (MC) Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Molluscum Contagiosum (MC) Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Molluscum Contagiosum (MC) Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Molluscum Contagiosum (MC) Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Molluscum Contagiosum (MC) Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Molluscum Contagiosum (MC) Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Molluscum Contagiosum (MC) Treatment Sales Growth
4.4 APAC Molluscum Contagiosum (MC) Treatment Sales Growth
4.5 Europe Molluscum Contagiosum (MC) Treatment Sales Growth
4.6 Middle East & Africa Molluscum Contagiosum (MC) Treatment Sales Growth
5 Americas
5.1 Americas Molluscum Contagiosum (MC) Treatment Sales by Country
5.1.1 Americas Molluscum Contagiosum (MC) Treatment Sales by Country (2018-2023)
5.1.2 Americas Molluscum Contagiosum (MC) Treatment Revenue by Country (2018-2023)
5.2 Americas Molluscum Contagiosum (MC) Treatment Sales by Type
5.3 Americas Molluscum Contagiosum (MC) Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molluscum Contagiosum (MC) Treatment Sales by Region
6.1.1 APAC Molluscum Contagiosum (MC) Treatment Sales by Region (2018-2023)
6.1.2 APAC Molluscum Contagiosum (MC) Treatment Revenue by Region (2018-2023)
6.2 APAC Molluscum Contagiosum (MC) Treatment Sales by Type
6.3 APAC Molluscum Contagiosum (MC) Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Molluscum Contagiosum (MC) Treatment by Country
7.1.1 Europe Molluscum Contagiosum (MC) Treatment Sales by Country (2018-2023)
7.1.2 Europe Molluscum Contagiosum (MC) Treatment Revenue by Country (2018-2023)
7.2 Europe Molluscum Contagiosum (MC) Treatment Sales by Type
7.3 Europe Molluscum Contagiosum (MC) Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Molluscum Contagiosum (MC) Treatment by Country
8.1.1 Middle East & Africa Molluscum Contagiosum (MC) Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Molluscum Contagiosum (MC) Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Molluscum Contagiosum (MC) Treatment Sales by Type
8.3 Middle East & Africa Molluscum Contagiosum (MC) Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Molluscum Contagiosum (MC) Treatment
10.3 Manufacturing Process Analysis of Molluscum Contagiosum (MC) Treatment
10.4 Industry Chain Structure of Molluscum Contagiosum (MC) Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Molluscum Contagiosum (MC) Treatment Distributors
11.3 Molluscum Contagiosum (MC) Treatment Customer
12 World Forecast Review for Molluscum Contagiosum (MC) Treatment by Geographic Region
12.1 Global Molluscum Contagiosum (MC) Treatment Market Size Forecast by Region
12.1.1 Global Molluscum Contagiosum (MC) Treatment Forecast by Region (2024-2029)
12.1.2 Global Molluscum Contagiosum (MC) Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Molluscum Contagiosum (MC) Treatment Forecast by Type
12.7 Global Molluscum Contagiosum (MC) Treatment Forecast by Application
13 Key Players Analysis
13.1 Competition Deep Dive
13.1.1 Competition Deep Dive Company Information
13.1.2 Competition Deep Dive Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
13.1.3 Competition Deep Dive Molluscum Contagiosum (MC) Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Competition Deep Dive Main Business Overview
13.1.5 Competition Deep Dive Latest Developments
13.2 Novan, Inc.
13.2.1 Novan, Inc. Company Information
13.2.2 Novan, Inc. Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
13.2.3 Novan, Inc. Molluscum Contagiosum (MC) Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Novan, Inc. Main Business Overview
13.2.5 Novan, Inc. Latest Developments
13.3 Veloce Biopharma
13.3.1 Veloce Biopharma Company Information
13.3.2 Veloce Biopharma Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
13.3.3 Veloce Biopharma Molluscum Contagiosum (MC) Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Veloce Biopharma Main Business Overview
13.3.5 Veloce Biopharma Latest Developments
13.4 Gurina Foundation
13.4.1 Gurina Foundation Company Information
13.4.2 Gurina Foundation Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
13.4.3 Gurina Foundation Molluscum Contagiosum (MC) Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Gurina Foundation Main Business Overview
13.4.5 Gurina Foundation Latest Developments
13.5 Azafaros
13.5.1 Azafaros Company Information
13.5.2 Azafaros Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
13.5.3 Azafaros Molluscum Contagiosum (MC) Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Azafaros Main Business Overview
13.5.5 Azafaros Latest Developments
13.6 Polaryx Therapeutics
13.6.1 Polaryx Therapeutics Company Information
13.6.2 Polaryx Therapeutics Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
13.6.3 Polaryx Therapeutics Molluscum Contagiosum (MC) Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Polaryx Therapeutics Main Business Overview
13.6.5 Polaryx Therapeutics Latest Developments
13.7 Abbott Medtronic
13.7.1 Abbott Medtronic Company Information
13.7.2 Abbott Medtronic Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
13.7.3 Abbott Medtronic Molluscum Contagiosum (MC) Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Abbott Medtronic Main Business Overview
13.7.5 Abbott Medtronic Latest Developments
13.8 Merck & Co., Inc.
13.8.1 Merck & Co., Inc. Company Information
13.8.2 Merck & Co., Inc. Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
13.8.3 Merck & Co., Inc. Molluscum Contagiosum (MC) Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Merck & Co., Inc. Main Business Overview
13.8.5 Merck & Co., Inc. Latest Developments
13.9 Pfizer Inc.
13.9.1 Pfizer Inc. Company Information
13.9.2 Pfizer Inc. Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
13.9.3 Pfizer Inc. Molluscum Contagiosum (MC) Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Pfizer Inc. Main Business Overview
13.9.5 Pfizer Inc. Latest Developments
13.10 Siemens Healthcare GmbH
13.10.1 Siemens Healthcare GmbH Company Information
13.10.2 Siemens Healthcare GmbH Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
13.10.3 Siemens Healthcare GmbH Molluscum Contagiosum (MC) Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Siemens Healthcare GmbH Main Business Overview
13.10.5 Siemens Healthcare GmbH Latest Developments
13.11 Novartis AG
13.11.1 Novartis AG Company Information
13.11.2 Novartis AG Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
13.11.3 Novartis AG Molluscum Contagiosum (MC) Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Novartis AG Main Business Overview
13.11.5 Novartis AG Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Molluscum Contagiosum (MC) Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Molluscum Contagiosum (MC) Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Cryotherapy
Table 4. Major Players of Immune-modulating Therapies
Table 5. Major Players of Topical Therapies
Table 6. Global Molluscum Contagiosum (MC) Treatment Sales by Type (2018-2023) & (K Units)
Table 7. Global Molluscum Contagiosum (MC) Treatment Sales Market Share by Type (2018-2023)
Table 8. Global Molluscum Contagiosum (MC) Treatment Revenue by Type (2018-2023) & ($ million)
Table 9. Global Molluscum Contagiosum (MC) Treatment Revenue Market Share by Type (2018-2023)
Table 10. Global Molluscum Contagiosum (MC) Treatment Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Molluscum Contagiosum (MC) Treatment Sales by Application (2018-2023) & (K Units)
Table 12. Global Molluscum Contagiosum (MC) Treatment Sales Market Share by Application (2018-2023)
Table 13. Global Molluscum Contagiosum (MC) Treatment Revenue by Application (2018-2023)
Table 14. Global Molluscum Contagiosum (MC) Treatment Revenue Market Share by Application (2018-2023)
Table 15. Global Molluscum Contagiosum (MC) Treatment Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Molluscum Contagiosum (MC) Treatment Sales by Company (2018-2023) & (K Units)
Table 17. Global Molluscum Contagiosum (MC) Treatment Sales Market Share by Company (2018-2023)
Table 18. Global Molluscum Contagiosum (MC) Treatment Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Molluscum Contagiosum (MC) Treatment Revenue Market Share by Company (2018-2023)
Table 20. Global Molluscum Contagiosum (MC) Treatment Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Molluscum Contagiosum (MC) Treatment Producing Area Distribution and Sales Area
Table 22. Players Molluscum Contagiosum (MC) Treatment Products Offered
Table 23. Molluscum Contagiosum (MC) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Molluscum Contagiosum (MC) Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Molluscum Contagiosum (MC) Treatment Sales Market Share Geographic Region (2018-2023)
Table 28. Global Molluscum Contagiosum (MC) Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Molluscum Contagiosum (MC) Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Molluscum Contagiosum (MC) Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Molluscum Contagiosum (MC) Treatment Sales Market Share by Country/Region (2018-2023)
Table 32. Global Molluscum Contagiosum (MC) Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Molluscum Contagiosum (MC) Treatment Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Molluscum Contagiosum (MC) Treatment Sales by Country (2018-2023) & (K Units)
Table 35. Americas Molluscum Contagiosum (MC) Treatment Sales Market Share by Country (2018-2023)
Table 36. Americas Molluscum Contagiosum (MC) Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Molluscum Contagiosum (MC) Treatment Revenue Market Share by Country (2018-2023)
Table 38. Americas Molluscum Contagiosum (MC) Treatment Sales by Type (2018-2023) & (K Units)
Table 39. Americas Molluscum Contagiosum (MC) Treatment Sales by Application (2018-2023) & (K Units)
Table 40. APAC Molluscum Contagiosum (MC) Treatment Sales by Region (2018-2023) & (K Units)
Table 41. APAC Molluscum Contagiosum (MC) Treatment Sales Market Share by Region (2018-2023)
Table 42. APAC Molluscum Contagiosum (MC) Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Molluscum Contagiosum (MC) Treatment Revenue Market Share by Region (2018-2023)
Table 44. APAC Molluscum Contagiosum (MC) Treatment Sales by Type (2018-2023) & (K Units)
Table 45. APAC Molluscum Contagiosum (MC) Treatment Sales by Application (2018-2023) & (K Units)
Table 46. Europe Molluscum Contagiosum (MC) Treatment Sales by Country (2018-2023) & (K Units)
Table 47. Europe Molluscum Contagiosum (MC) Treatment Sales Market Share by Country (2018-2023)
Table 48. Europe Molluscum Contagiosum (MC) Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Molluscum Contagiosum (MC) Treatment Revenue Market Share by Country (2018-2023)
Table 50. Europe Molluscum Contagiosum (MC) Treatment Sales by Type (2018-2023) & (K Units)
Table 51. Europe Molluscum Contagiosum (MC) Treatment Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Molluscum Contagiosum (MC) Treatment Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Molluscum Contagiosum (MC) Treatment Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Molluscum Contagiosum (MC) Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Molluscum Contagiosum (MC) Treatment Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Molluscum Contagiosum (MC) Treatment Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Molluscum Contagiosum (MC) Treatment Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Molluscum Contagiosum (MC) Treatment
Table 59. Key Market Challenges & Risks of Molluscum Contagiosum (MC) Treatment
Table 60. Key Industry Trends of Molluscum Contagiosum (MC) Treatment
Table 61. Molluscum Contagiosum (MC) Treatment Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Molluscum Contagiosum (MC) Treatment Distributors List
Table 64. Molluscum Contagiosum (MC) Treatment Customer List
Table 65. Global Molluscum Contagiosum (MC) Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Molluscum Contagiosum (MC) Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Molluscum Contagiosum (MC) Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Molluscum Contagiosum (MC) Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Molluscum Contagiosum (MC) Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Molluscum Contagiosum (MC) Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Molluscum Contagiosum (MC) Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Molluscum Contagiosum (MC) Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Molluscum Contagiosum (MC) Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Molluscum Contagiosum (MC) Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Molluscum Contagiosum (MC) Treatment Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Molluscum Contagiosum (MC) Treatment Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Molluscum Contagiosum (MC) Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Molluscum Contagiosum (MC) Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Competition Deep Dive Basic Information, Molluscum Contagiosum (MC) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 80. Competition Deep Dive Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
Table 81. Competition Deep Dive Molluscum Contagiosum (MC) Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Competition Deep Dive Main Business
Table 83. Competition Deep Dive Latest Developments
Table 84. Novan, Inc. Basic Information, Molluscum Contagiosum (MC) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 85. Novan, Inc. Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
Table 86. Novan, Inc. Molluscum Contagiosum (MC) Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Novan, Inc. Main Business
Table 88. Novan, Inc. Latest Developments
Table 89. Veloce Biopharma Basic Information, Molluscum Contagiosum (MC) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 90. Veloce Biopharma Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
Table 91. Veloce Biopharma Molluscum Contagiosum (MC) Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Veloce Biopharma Main Business
Table 93. Veloce Biopharma Latest Developments
Table 94. Gurina Foundation Basic Information, Molluscum Contagiosum (MC) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 95. Gurina Foundation Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
Table 96. Gurina Foundation Molluscum Contagiosum (MC) Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Gurina Foundation Main Business
Table 98. Gurina Foundation Latest Developments
Table 99. Azafaros Basic Information, Molluscum Contagiosum (MC) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 100. Azafaros Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
Table 101. Azafaros Molluscum Contagiosum (MC) Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Azafaros Main Business
Table 103. Azafaros Latest Developments
Table 104. Polaryx Therapeutics Basic Information, Molluscum Contagiosum (MC) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 105. Polaryx Therapeutics Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
Table 106. Polaryx Therapeutics Molluscum Contagiosum (MC) Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Polaryx Therapeutics Main Business
Table 108. Polaryx Therapeutics Latest Developments
Table 109. Abbott Medtronic Basic Information, Molluscum Contagiosum (MC) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 110. Abbott Medtronic Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
Table 111. Abbott Medtronic Molluscum Contagiosum (MC) Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Abbott Medtronic Main Business
Table 113. Abbott Medtronic Latest Developments
Table 114. Merck & Co., Inc. Basic Information, Molluscum Contagiosum (MC) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 115. Merck & Co., Inc. Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
Table 116. Merck & Co., Inc. Molluscum Contagiosum (MC) Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Merck & Co., Inc. Main Business
Table 118. Merck & Co., Inc. Latest Developments
Table 119. Pfizer Inc. Basic Information, Molluscum Contagiosum (MC) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 120. Pfizer Inc. Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
Table 121. Pfizer Inc. Molluscum Contagiosum (MC) Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Pfizer Inc. Main Business
Table 123. Pfizer Inc. Latest Developments
Table 124. Siemens Healthcare GmbH Basic Information, Molluscum Contagiosum (MC) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 125. Siemens Healthcare GmbH Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
Table 126. Siemens Healthcare GmbH Molluscum Contagiosum (MC) Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Siemens Healthcare GmbH Main Business
Table 128. Siemens Healthcare GmbH Latest Developments
Table 129. Novartis AG Basic Information, Molluscum Contagiosum (MC) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 130. Novartis AG Molluscum Contagiosum (MC) Treatment Product Portfolios and Specifications
Table 131. Novartis AG Molluscum Contagiosum (MC) Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Novartis AG Main Business
Table 133. Novartis AG Latest Developments
List of Figures
Figure 1. Picture of Molluscum Contagiosum (MC) Treatment
Figure 2. Molluscum Contagiosum (MC) Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Molluscum Contagiosum (MC) Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Molluscum Contagiosum (MC) Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Molluscum Contagiosum (MC) Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Cryotherapy
Figure 10. Product Picture of Immune-modulating Therapies
Figure 11. Product Picture of Topical Therapies
Figure 12. Global Molluscum Contagiosum (MC) Treatment Sales Market Share by Type in 2022
Figure 13. Global Molluscum Contagiosum (MC) Treatment Revenue Market Share by Type (2018-2023)
Figure 14. Molluscum Contagiosum (MC) Treatment Consumed in Hospital
Figure 15. Global Molluscum Contagiosum (MC) Treatment Market: Hospital (2018-2023) & (K Units)
Figure 16. Molluscum Contagiosum (MC) Treatment Consumed in Skin Clinics
Figure 17. Global Molluscum Contagiosum (MC) Treatment Market: Skin Clinics (2018-2023) & (K Units)
Figure 18. Molluscum Contagiosum (MC) Treatment Consumed in Immunocompromised Patients
Figure 19. Global Molluscum Contagiosum (MC) Treatment Market: Immunocompromised Patients (2018-2023) & (K Units)
Figure 20. Global Molluscum Contagiosum (MC) Treatment Sales Market Share by Application (2022)
Figure 21. Global Molluscum Contagiosum (MC) Treatment Revenue Market Share by Application in 2022
Figure 22. Molluscum Contagiosum (MC) Treatment Sales Market by Company in 2022 (K Units)
Figure 23. Global Molluscum Contagiosum (MC) Treatment Sales Market Share by Company in 2022
Figure 24. Molluscum Contagiosum (MC) Treatment Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Molluscum Contagiosum (MC) Treatment Revenue Market Share by Company in 2022
Figure 26. Global Molluscum Contagiosum (MC) Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Molluscum Contagiosum (MC) Treatment Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Molluscum Contagiosum (MC) Treatment Sales 2018-2023 (K Units)
Figure 29. Americas Molluscum Contagiosum (MC) Treatment Revenue 2018-2023 ($ Millions)
Figure 30. APAC Molluscum Contagiosum (MC) Treatment Sales 2018-2023 (K Units)
Figure 31. APAC Molluscum Contagiosum (MC) Treatment Revenue 2018-2023 ($ Millions)
Figure 32. Europe Molluscum Contagiosum (MC) Treatment Sales 2018-2023 (K Units)
Figure 33. Europe Molluscum Contagiosum (MC) Treatment Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Molluscum Contagiosum (MC) Treatment Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Molluscum Contagiosum (MC) Treatment Revenue 2018-2023 ($ Millions)
Figure 36. Americas Molluscum Contagiosum (MC) Treatment Sales Market Share by Country in 2022
Figure 37. Americas Molluscum Contagiosum (MC) Treatment Revenue Market Share by Country in 2022
Figure 38. Americas Molluscum Contagiosum (MC) Treatment Sales Market Share by Type (2018-2023)
Figure 39. Americas Molluscum Contagiosum (MC) Treatment Sales Market Share by Application (2018-2023)
Figure 40. United States Molluscum Contagiosum (MC) Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Molluscum Contagiosum (MC) Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Molluscum Contagiosum (MC) Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Molluscum Contagiosum (MC) Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Molluscum Contagiosum (MC) Treatment Sales Market Share by Region in 2022
Figure 45. APAC Molluscum Contagiosum (MC) Treatment Revenue Market Share by Regions in 2022
Figure 46. APAC Molluscum Contagiosum (MC) Treatment Sales Market Share by Type (2018-2023)
Figure 47. APAC Molluscum Contagiosum (MC) Treatment Sales Market Share by Application (2018-2023)
Figure 48. China Molluscum Contagiosum (MC) Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Molluscum Contagiosum (MC) Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Molluscum Contagiosum (MC) Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Molluscum Contagiosum (MC) Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Molluscum Contagiosum (MC) Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Molluscum Contagiosum (MC) Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Molluscum Contagiosum (MC) Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Molluscum Contagiosum (MC) Treatment Sales Market Share by Country in 2022
Figure 56. Europe Molluscum Contagiosum (MC) Treatment Revenue Market Share by Country in 2022
Figure 57. Europe Molluscum Contagiosum (MC) Treatment Sales Market Share by Type (2018-2023)
Figure 58. Europe Molluscum Contagiosum (MC) Treatment Sales Market Share by Application (2018-2023)
Figure 59. Germany Molluscum Contagiosum (MC) Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Molluscum Contagiosum (MC) Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Molluscum Contagiosum (MC) Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Molluscum Contagiosum (MC) Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Molluscum Contagiosum (MC) Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Molluscum Contagiosum (MC) Treatment Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Molluscum Contagiosum (MC) Treatment Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Molluscum Contagiosum (MC) Treatment Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Molluscum Contagiosum (MC) Treatment Sales Market Share by Application (2018-2023)
Figure 68. Egypt Molluscum Contagiosum (MC) Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Molluscum Contagiosum (MC) Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Molluscum Contagiosum (MC) Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Molluscum Contagiosum (MC) Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Molluscum Contagiosum (MC) Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Molluscum Contagiosum (MC) Treatment in 2022
Figure 74. Manufacturing Process Analysis of Molluscum Contagiosum (MC) Treatment
Figure 75. Industry Chain Structure of Molluscum Contagiosum (MC) Treatment
Figure 76. Channels of Distribution
Figure 77. Global Molluscum Contagiosum (MC) Treatment Sales Market Forecast by Region (2024-2029)
Figure 78. Global Molluscum Contagiosum (MC) Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Molluscum Contagiosum (MC) Treatment Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Molluscum Contagiosum (MC) Treatment Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Molluscum Contagiosum (MC) Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Molluscum Contagiosum (MC) Treatment Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の伝染性軟属腫（MC）治療市場予測 2023年-2029年] (コード：LP23DC07102)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の伝染性軟属腫（MC）治療市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のモリブデン補因子欠乏 A型（MoCoD-A）治療市場予測 2023年-2029年
  • 世界の意義不明の単クローン性高分子免疫グロブリン血症（MGUS）治療市場予測 2023年-2029年
  • 世界の多汗症治療用ボトックス市場予測 2023年-2029年
  • 世界のシュニッツラー症候群治療市場予測 2023年-2029年
  • 世界の矯正治療用製品市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆